Mindfulness-Based Cognitive Therapy for the Treatment of Chronic Headache Pain
NCT ID: NCT01213056
Last Updated: 2015-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
32 participants
INTERVENTIONAL
2010-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will provide a research base examining the feasibility and efficacy of MBCT for pain. Results from this study will lay the foundation for future randomized controlled trials comparing MBCT to attention control, and future comparative effectiveness studies of MBCT and CBT.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Specific Aims The proposed project is a feasibility study designed to test the MBCT protocol for chronic pain treatment and to provide pilot data to support subsequent research proposals to be submitted to the National Institutes of Health. In this initial trial the investigators will use patients with primary complaints of headache pain and treat them at a collaborating headache clinic. We selected this target population because headache pain is highly disabling and is the most common pain related complaint treated in medical practice. Furthermore, given the time frame of the study, it is more feasible to recruit patients where the PI has an established and ongoing collaborative relationship. The proposed project emphasizes the research area of health, medicine, and behavior.
Aim 1: To examine feasibility of the treatment, data will be collected regarding participant flow across each stage of the study design, including recruitment, participation, and drop-out rates, and percentage of sessions attended. Furthermore, pre-treatment expectations, post-treatment satisfaction, and global ratings of self-perceived improvement will be assessed.
Hypotheses: It is expected that the feasibility of MBCT, as measured by the above indicators, will be comparable to similar data for other psychosocial treatments for pain, such as CBT.
Aim 2: As an initial test of the efficacy of MBCT for chronic pain, the investigators will compare an immediate treatment condition to a delayed treatment (OT) control on pre- and post-intervention measures. Time constraints of the current project will necessitate follow-up assessment to be part of future proposals.
Hypotheses: Participants in the immediate treatment condition will obtain significantly greater pre-post treatment gains compared to OT on primary outcome measures of pain acceptance, pain catastrophizing, and pain interference; and secondary outcome measures of mindfulness, pain intensity, perceived disability, selfefficacy, quality of life, and depression.
Long-term objectives: Future projects will include a randomized controlled trial (RCT) comparing MBCT to an attention control condition (education support group), and eventually a comparative effectiveness stUdy of CBT vs. MBCT.
Innovative aspects of the proposed study: This is the first examination of MBCT for chronic pain, which incorporates specific components of mindfulness and cognitive behavioral therapy to form a comprehensive treatment approach.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness Based Cognitive Therapy * (MBCT)
Mindfulness based cognitive therapy aimed to improve coping with, and managing chronic headache pain.
Mindfulness Based Cognitive Therapy
Cognitive Behavioral (Active treatment condition)
Delayed Treatment Control * (DT)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness Based Cognitive Therapy
Cognitive Behavioral (Active treatment condition)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent evaluation (within 6 months) of headaches by a physician, participants will also need to receive permission from their physician to take part in the study;
* Age of 19 years or older;
* Reading ability sufficient to comprehend self-monitoring forms;
* If currently using psychotropic or headache medications, use of these medications must have begun at least 4-weeks before treatment; and
* Agree to be videotaped during the group treatment sessions, although the video camera will be directed at the group leader, and not directed at the participant.
Exclusion Criteria
* Significant cognitive impairment;
* History of schizophrenia, bipolar affective disorder or substance abuse as these conditions could result in a psychiatric emergency during treatment
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama, Tuscaloosa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beverly E Thorn, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Alabama, Tuscaloosa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UATuscaloosa
Tuscaloosa, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-0378
Identifier Type: -
Identifier Source: org_study_id